CD14 and type 2 diabetes mellitus: Increased phenotypically switched FSC‐Hi monocytes and decreased CD14 expression in the T2D monocyte pool (Fig 1B) indicate that patients with COVID‐19 and T2D present a hyperinflammatory phenotype due to exacerbated loss of classical monocytes.